[HTML][HTML] Vaccine adjuvants: from 1920 to 2015 and beyond

A Di Pasquale, S Preiss, F Tavares Da Silva, N Garçon - Vaccines, 2015 - mdpi.com
The concept of stimulating the body's immune response is the basis underlying vaccination.
Vaccines act by initiating the innate immune response and activating antigen presenting …

Pertussis: microbiology, disease, treatment, and prevention

PE Kilgore, AM Salim, MJ Zervos… - Clinical microbiology …, 2016 - Am Soc Microbiol
Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

JM Warfel, LI Zimmerman… - Proceedings of the …, 2014 - National Acad Sciences
Pertussis is a highly contagious respiratory illness caused by the bacterial pathogen
Bordetella pertussis. Pertussis rates in the United States have been rising and reached a 50 …

Pertussis resurgence: waning immunity and pathogen adaptation–two sides of the same coin

FR Mooi, NAT Van Der Maas… - Epidemiology & Infection, 2014 - cambridge.org
Pertussis or whooping cough has persisted and resurged in the face of vaccination and has
become one of the most prevalent vaccine-preventable diseases in Western countries. The …

Number and order of whole cell pertussis vaccines in infancy and disease protection

SL Sheridan, RS Ware, K Grimwood, SB Lambert - Jama, 2012 - jamanetwork.com
To the Editor: I would like to report an incomplete financial disclosure related to a Viewpoint
published in JAMA. 1 While the topic of the Viewpoint was complementary and alternative …

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

MA Witt, PH Katz, DJ Witt - Clinical Infectious Diseases, 2012 - academic.oup.com
Background. Despite widespread childhood vaccination against Bordetella pertussis,
disease remains prevalent. It has been suggested that acellular vaccine may be less …

Duration of pertussis immunity after DTaP immunization: a meta-analysis

A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …

[HTML][HTML] Pertussis re-emergence in the post-vaccination era

E Chiappini, A Stival, L Galli, M De Martino - BMC infectious diseases, 2013 - Springer
Background Resurgence of pertussis in the post-vaccination era has been reported in
Western countries. A shift of cases from school-age children to adolescents, adults and …

[HTML][HTML] Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL …

AC Allen, MM Wilk, A Misiak, L Borkner, D Murphy… - Mucosal …, 2018 - Elsevier
Current acellular pertussis (aP) vaccines induce strong antibody and Th2 responses but fail
to protect against nasal colonization and transmission of Bordetella pertussis. Furthermore …

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

MA Witt, L Arias, PH Katz, ET Truong… - Clinical infectious …, 2013 - academic.oup.com
Background. Unexpected waning of immunity after pertussis vaccination is now well
described. In this study we examined whether prior vaccination with whole-cell pertussis …